These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
420 related articles for article (PubMed ID: 18162851)
21. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events. MacLaren R; Bond CA Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249 [TBL] [Abstract][Full Text] [Related]
22. Economic implications of an evidence-based sepsis protocol: can we improve outcomes and lower costs? Shorr AF; Micek ST; Jackson WL; Kollef MH Crit Care Med; 2007 May; 35(5):1257-62. PubMed ID: 17414080 [TBL] [Abstract][Full Text] [Related]
23. The association between nighttime transfer from the intensive care unit and patient outcome. Hanane T; Keegan MT; Seferian EG; Gajic O; Afessa B Crit Care Med; 2008 Aug; 36(8):2232-7. PubMed ID: 18664778 [TBL] [Abstract][Full Text] [Related]
24. An analgesia-delirium-sedation protocol for critically ill trauma patients reduces ventilator days and hospital length of stay. Robinson BR; Mueller EW; Henson K; Branson RD; Barsoum S; Tsuei BJ J Trauma; 2008 Sep; 65(3):517-26. PubMed ID: 18784563 [TBL] [Abstract][Full Text] [Related]
25. Intermittent hemodialysis versus continuous renal replacement therapy for acute renal failure in the intensive care unit: an observational outcomes analysis. Rauf AA; Long KH; Gajic O; Anderson SS; Swaminathan L; Albright RC J Intensive Care Med; 2008; 23(3):195-203. PubMed ID: 18474503 [TBL] [Abstract][Full Text] [Related]
26. Influence of adverse drug events on morbidity and mortality in intensive care units: the JADE study. Ohta Y; Sakuma M; Koike K; Bates DW; Morimoto T Int J Qual Health Care; 2014 Dec; 26(6):573-8. PubMed ID: 25192926 [TBL] [Abstract][Full Text] [Related]
27. Errors in preparation and administration of intravenous medications in the intensive care unit of a teaching hospital: an observational study. Fahimi F; Ariapanah P; Faizi M; Shafaghi B; Namdar R; Ardakani MT Aust Crit Care; 2008 May; 21(2):110-6. PubMed ID: 18387813 [TBL] [Abstract][Full Text] [Related]
28. Medication safety in a psychiatric hospital. Rothschild JM; Mann K; Keohane CA; Williams DH; Foskett C; Rosen SL; Flaherty L; Chu JA; Bates DW Gen Hosp Psychiatry; 2007; 29(2):156-62. PubMed ID: 17336665 [TBL] [Abstract][Full Text] [Related]
29. Adverse drug events in adult patients leading to emergency department visits. Sikdar KC; Alaghehbandan R; MacDonald D; Barrett B; Collins KD; Donnan J; Gadag V Ann Pharmacother; 2010 Apr; 44(4):641-9. PubMed ID: 20233911 [TBL] [Abstract][Full Text] [Related]
30. Growth of intensive care unit resource use and its estimated cost in Medicare. Milbrandt EB; Kersten A; Rahim MT; Dremsizov TT; Clermont G; Cooper LM; Angus DC; Linde-Zwirble WT Crit Care Med; 2008 Sep; 36(9):2504-10. PubMed ID: 18679127 [TBL] [Abstract][Full Text] [Related]
31. Intensive care unit drug utilization in a teaching hospital in Nepal. Shankar PR; Partha P; Dubey AK; Mishra P; Deshpande VY Kathmandu Univ Med J (KUMJ); 2005; 3(2):130-7. PubMed ID: 16415608 [TBL] [Abstract][Full Text] [Related]
32. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay. Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876 [TBL] [Abstract][Full Text] [Related]
33. Effect of reduction of postoperative days in the intensive care unit after coronary artery bypass. Vander Salm TJ; Blair SA J Thorac Cardiovasc Surg; 1984 Oct; 88(4):558-61. PubMed ID: 6332952 [TBL] [Abstract][Full Text] [Related]
34. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. Bates DW; Spell N; Cullen DJ; Burdick E; Laird N; Petersen LA; Small SD; Sweitzer BJ; Leape LL JAMA; 1997 Jan 22-29; 277(4):307-11. PubMed ID: 9002493 [TBL] [Abstract][Full Text] [Related]
35. Brain injury and fever: hospital length of stay and cost outcomes. Reaven NL; Lovett JE; Funk SE J Intensive Care Med; 2009; 24(2):131-9. PubMed ID: 19188268 [TBL] [Abstract][Full Text] [Related]
36. Impact of a pharmacy resident on hospital length of stay and drug-related costs. Terceros Y; Chahine-Chakhtoura C; Malinowski JE; Rickley WF Ann Pharmacother; 2007 May; 41(5):742-8. PubMed ID: 17440008 [TBL] [Abstract][Full Text] [Related]
37. The national burden of E-code-identified adverse drug events among hospitalized children using a national discharge database. Tundia NL; Heaton PC; Kelton CM Pharmacoepidemiol Drug Saf; 2011 Aug; 20(8):866-78. PubMed ID: 21574209 [TBL] [Abstract][Full Text] [Related]
38. Variation in length of intensive care unit stay after cardiac arrest: where you are is as important as who you are. Keenan SP; Dodek P; Martin C; Priestap F; Norena M; Wong H Crit Care Med; 2007 Mar; 35(3):836-41. PubMed ID: 17255864 [TBL] [Abstract][Full Text] [Related]
39. Costs of the COPD. Differences between intensive care unit and respiratory intermediate care unit. Bertolini G; Confalonieri M; Rossi C; Rossi G; Simini B; Gorini M; Corrado A; ; Respir Med; 2005 Jul; 99(7):894-900. PubMed ID: 15939252 [TBL] [Abstract][Full Text] [Related]
40. Effectiveness and efficiency of intensive care medicine: variable costs in different diagnosis groups. Iapichino G; Radrizzani D; Simini B; Rossi C; Albicini M; Ferla L; Colombo A; Pezzi A; Brazzi L; Melotti R; Rossi G; Acta Anaesthesiol Scand; 2004 Aug; 48(7):820-6. PubMed ID: 15242425 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]